Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Nunes

Showing results (141-150 of 609) with videos related to

Pageof 61
Sort By:
Addiction Science & Clinical Practice|March 7, 2021
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)"Matisyahu Shulman, Roger Weiss, John Rotrosen, et al.
Drug and Alcohol Dependence Reports|October 3, 2022
Under-representation of key demographic groups in opioid use disorder trialsKara E Rudolph, Matthew Russell, Sean X Luo, et al.
Revista Clinica Espanola|April 1, 1989
[Prenatal diagnosis in a family carrying the fragile X syndrome using recombinant DNA technics]J Benítez, E Fernández, C Ramos, et al.
Drug and Alcohol Dependence|September 17, 2021
Optimizing opioid use disorder treatment with naltrexone or buprenorphineKara E Rudolph, Iván Díaz, Sean X Luo, et al.
Molecular Genetics and Metabolism|February 13, 2001
Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigreesM Gómez-Zaera, T M Strom, B Rodríguez, et al.
Nucleic Acids Research|March 11, 1990
ScrfI restriction fragment length polymorphism at the D7S23 locus (probe pKM. 19), closely linked to cystic fibrosisV Nunes, M Ramsay, T Casals, et al.
Addiction (Abingdon, England)|August 2, 2021
Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapseKara E Rudolph, Matisyahu Shulman, Marc Fishman, et al.
The American Journal of Drug and Alcohol Abuse|November 28, 2006
Behavior therapy for depression in drug dependence (BTDD): results of a stage Ia therapy development pilotKenneth M Carpenter, Efrat Aharonovich, Jennifer L Smith, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 10, 2013
Cognitive impairment in euthymic older adults with bipolar disorder: a controlled study using cognitive screening testsIvan Aprahamian, Rodolfo B Ladeira, Breno S Diniz, et al.
AIDS and Behavior|May 23, 2012
Predictors of relationship power among drug-involved womenAimee N C Campbell, Susan Tross, Mei-chen Hu, et al.
Pageof 61

Showing results (141-150 of 609) with videos related to

Sort By:
Pageof 61
Addiction Science & Clinical Practice|March 7, 2021
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)"Matisyahu Shulman, Roger Weiss, John Rotrosen, et al.
Drug and Alcohol Dependence Reports|October 3, 2022
Under-representation of key demographic groups in opioid use disorder trialsKara E Rudolph, Matthew Russell, Sean X Luo, et al.
Revista Clinica Espanola|April 1, 1989
[Prenatal diagnosis in a family carrying the fragile X syndrome using recombinant DNA technics]J Benítez, E Fernández, C Ramos, et al.
Drug and Alcohol Dependence|September 17, 2021
Optimizing opioid use disorder treatment with naltrexone or buprenorphineKara E Rudolph, Iván Díaz, Sean X Luo, et al.
Molecular Genetics and Metabolism|February 13, 2001
Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigreesM Gómez-Zaera, T M Strom, B Rodríguez, et al.
Nucleic Acids Research|March 11, 1990
ScrfI restriction fragment length polymorphism at the D7S23 locus (probe pKM. 19), closely linked to cystic fibrosisV Nunes, M Ramsay, T Casals, et al.
Addiction (Abingdon, England)|August 2, 2021
Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapseKara E Rudolph, Matisyahu Shulman, Marc Fishman, et al.
The American Journal of Drug and Alcohol Abuse|November 28, 2006
Behavior therapy for depression in drug dependence (BTDD): results of a stage Ia therapy development pilotKenneth M Carpenter, Efrat Aharonovich, Jennifer L Smith, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 10, 2013
Cognitive impairment in euthymic older adults with bipolar disorder: a controlled study using cognitive screening testsIvan Aprahamian, Rodolfo B Ladeira, Breno S Diniz, et al.
AIDS and Behavior|May 23, 2012
Predictors of relationship power among drug-involved womenAimee N C Campbell, Susan Tross, Mei-chen Hu, et al.
Pageof 61